Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer

Completed

Conditions studied: Breast Cancer

In brief

This study retrospectively looks at changes in Echocardiographic parameters while using transtuzumab

Key facts

Study ID

NCT03123263

Run by

Texas Tech University Health Sciences Center, El Paso

People needed

60

Starts

2017-04-11

Expected to finish

2019-02-26

Last updated by the study team

2019-09-09

Who can join

Age: 18 and older, up to 90. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Stage 1,2,3 breast cancer
• Her2+

You may not qualify if…

• Stage 4 cancer

Where it is running

• Ttuhsc — El Paso, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.